In this clinical update, we selected recent publications relevant to common neurological concerns in women, with specific attention to stroke, cognition, and headache. We have chosen to highlight articles on sex differences in stroke and stroke treatment, the effect of hormone therapy on stroke risk and on cognition, and symptoms of the migraine postdrome.
Get full access to this article
View all access options for this article.
References
1.
The North American Menopause Society. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause, 2012; 19:257–271.
2.
CanonicoM, OgerE, Plu-BureauG, et al.Hormone therapy and venous thromboembolism among postmenopausal women: Impact of the route of estrogen administration and progestogens: The ESTHER Study. Circulation, 2007; 115:840–845.
3.
GarganoJW, ReevesMJ, for the Paul Coverdell National Acute Stroke Registry Michigan PrototypeInvestigators. Sex differences in stroke recovery and stroke-specific quality of life: Results from a Statewide Stroke Registry. Stroke, 2007; 38:2541–2548.
4.
SchwammLH, FonarowGC, ReevesMJ, et al.Get with the guidelines-stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation, 2009; 119:107–115.
5.
National Center for Health Statistics. Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities. Hyattsville MD. 2016.
6.
BushnellCD, HurnP, ColtonC, et al.Advancing the study of stroke in women: Summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke, 2006; 37:2387–2399.
7.
HodisHN, CollinsP, MackWJ, SchierbeckLL. The timing hypothesis for coronary heart disease prevention with hormone therapy: Past, present and future in perspective. Climacteric, 2012; 15:217–228.
MakiPM. Critical window hypothesis of hormone therapy and cognition. Menopause, 2013; 20:695–709.
10.
KantarciK, LoweVJ, LesnickTG, et al.Early postmenopausal transdermal 17β-estradiol therapy and amyloid-β deposition. J Alzheimers Dis, 2016; 53:547–556.
11.
VetvikKG, MacGregorEA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol, 2017; 16:76–87.
12.
CadyRK, SchreiberCP, FarmerKU. Understanding the patient with migraine: The evolution from episodic headache to chronic neurologic disease. A proposed classification of patients with headache. Headache, 2004; 44:426–435.
13.
Ng-MakDS, FitzgeraldKA, NorquistJM, et al.Key concepts of migraine postdrome: A qualitative study to develop a post-migraine questionnaire. Headache, 2011; 51:105–117.
